Trials / Terminated
TerminatedNCT00512577
Transfusion Alternatives Pre-operatively in Sickle Cell Disease (TAPS)
Transfusion Alternatives Pre-operatively in Sickle Cell Disease
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- NHS Blood and Transplant · Other Government
- Sex
- All
- Age
- 1 Year
- Healthy volunteers
- Not accepted
Summary
TAPS is a sequential trial which aims to investigate whether the administration of a blood transfusion pre-operatively to patients with sickle cell disease (HB SS or Hb SB0 thal)having low or medium risk elective surgery increases or decreases the overall rate of peri-operative complications. The proportion of patients with peri-operative complications in two randomised groups of transfused and untransfused patients will be compared.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Red blood cell transfusion | Pre-operative red blood cell transfusion |
Timeline
- Start date
- 2007-07-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2007-08-07
- Last updated
- 2023-03-23
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00512577. Inclusion in this directory is not an endorsement.